Magrolimab
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
Product Specifications
CAS Number
2169232-81-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7086686 Inquire
Recombinant Pongo pygmaeus Cytochrome b-c1 complex subunit Rieske, mitochondrial (UQCRFS1), partial
Sign In for Pricing
View Details